Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS

NCT00847678 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Cryptococcal Meningitis

Interventions

BIOLOGICAL: Efungumab (Mycograb)
BIOLOGICAL: placebo
BIOLOGICAL: Amphotericin B
BIOLOGICAL: 5 flucytosine

Sponsor

Novartis Pharmaceuticals